`
Thursday, 17 August 2017

Drug Discovery News

  • Kowa Pharma and Eli Lilly release PK study result

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 23 Jul, 2012

    Singapore: Kowa Pharmaceuticals and Eli Lilly released results from a pharmacokinetic (PK) study exploring potential drug interaction between the cholesterol medication pitavastatin (LIVALO...Read more

  • TWi's diabetes drug recieves patent allowance from Europe, Russia

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 03 Aug, 2015

    Singapore: Taiwan based TWi Biotechnology has received patent allowance for AC-201, its lead drug candidate, from the European Patent Office and the Patent Office of the Russian Federation....Read more

  • Japanese stem cell company ReproCELL acquires Biopta

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 26 Nov, 2015

    Tokyo: Japanese regenerative medicine company ReproCELL Inc. has announced the acquisition of the Scottish life sciences company, Biopta. The acquisition of Biopta and its US subsidiary, B...Read more

  • IBM, A*Star co-develop anti-microbial hydrogel

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 24 Jan, 2013

    Singapore: Researchers from A*Star's Institute of Bioengineering and Nanotechnology (IBN) and IBM have unveiled first-ever antimicrobial hydrogel that can break apart biofilms and destroy ...Read more

  • Pfizer launches targeted therapy for lung cancer in Singapore

    Drug Discovery |  Regulatory | By BioSpectrum Bureau | 0 Comment | 04 Aug, 2015

    Singapore: Pfizer has launched Xalkori, a targeted therapy for ALK-positive non-small cell lung cancer (NSCLC), in Singapore. Xalkori is used to treat patients with late-stage (locally adv...Read more

  • HSA nod for Aslan rheumatoid arthritis drug

    Drug Discovery |  Regulatory | By BioSpectrum Bureau | 0 Comment | 23 Apr, 2013

    Singapore: Aslan Pharmaceuticals received approval by the Singapore Health Sciences Authority (HSA) for its Clinical Trial Certificate Application for ASLAN003, which is a novel oral small ...Read more

  • Celsion launches cancer drug trial in China

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 08 Mar, 2016

    Singapore: Celsion Corporation, a fully-integrated oncology company focused on the development of a portfolio of innovative cancer treatments, has launched OPTIMA Study in China. The OPTIM...Read more

  • China SFDA passes Sihuan Pharma's Roxatidine

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 28 May, 2012

    Singapore: Sihuan Pharmaceutical Holdings' roxatidine acetate hydrochloride for injection (Roxatidine), which is the company's first-to-market generic drug, passed on-site inspection for dr...Read more

  • Takeda, DND to accelerate drug discovery for parasite infection

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 29 Jul, 2015

    Singapore: Geneva based Drugs for Neglected Diseases and Japan's Takeda have collaborated for a Lead Optimization Program aimed at identifying the best compound among aminopyrazole series f...Read more

  • Abbott marks success with naturally dissolving stent in Japan

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 02 Sep, 2015

    Global life sciences company Abbott has announced that the company has observed positive clinical results from ABSORB Japan, a multi-center, one-year randomized trial comparing the safety a...Read more

  • BI shows afatinib to be effective in advanced squamous cell carcinoma of lung

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 11 Jun, 2015

    Singapore: Boehringer Ingelheim has achieved positive results from the trial of afatinib in comparison to erlotinib in patients with advanced squamous cell carcinoma (SCC) of the lung. The...Read more

  • Novartis partners with Mereo BioPharma to enhance novel drug portfolio

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 31 Jul, 2015

    Singapore: Novartis has partnered with UK based Mereo BioPharma to develop compounds including BPS-804, to improve bone density in brittle bone syndrome, an orphan disease; BCT-197 for acut...Read more

  • Jubilant Biosys collaborates with Sanofi to develop metabolic disorders therapy

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 11 Jan, 2016

    Singapore: India based Jubilant Biosys, subsidiary of Jubilant Life Sciences, and Germany based Sanofi Deutschland have announced a strategic alliance to discover and develop small molecule...Read more

  • Amgen terninates phase III cancer trial

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 09 Aug, 2012

    Singapore: Amgen decided to stop the ganitumab (AMG 479) phase III GAMMA (gemcitabine and AMG 479 in metastatic adenocarcinoma of the pancreas) trial following the recommendation of an inde...Read more

  • Minerva derives positive outcome of Insomnia drug study in Japanese patients

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 02 Feb, 2016

    NASDAQ-listed Minerva Neurosciences Inc, a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system (CNS) disorders, has derived top line ...Read more

  • Singapore cancer genome scientists win President's Science Award

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 17 Sep, 2015

    Singapore: A team comprising Professor Patrick Tan from Duke-NUS Graduate Medical School (Duke-NUS) and A*STAR's Genome Institute of Singapore (GIS), Professor Teh Bin Tean from the Nationa...Read more

  • Positive results for Otsuka's MDR-TB treatment

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 07 Jun, 2012

    Singapore: Clinical trial results on the safety and efficacy of delamanid, Otsuka Pharmaceutical's investigational compound for the treatment of multidrug-resistant tuberculosis (MDR-TB), s...Read more

  • Boehringer, Lilly complete type 2 diabetes study

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 12 Nov, 2012

    Singapore: Recruitment of patients for CAROLINA (cardiovascular outcome study of Linagliptin versus Glimepiride in patients with type 2 diabetes) by Boehringer Ingelheim and Eli Lilly has b...Read more

Orchard Therapeutics appoin...

Survey Box

Does Asia have more to offer to the global 3D cell culture market?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls